Ginkgo Bioworks Holdings, Inc. DNA
7.43 USD -0.77 (-9.39%)
As ofNov 20, 2026, 2:33 PM EST
7.41 Day range 7.76
5.37 52-week range 18.22
- YTD
- -10.59%
- 1 year
- -4.99%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 170.16M | 227.04M | 251.46M | 477.71M | 313.84M | |
| 123.18M | 182.50M | 197.45M | 273.49M | 184.15M | |
| -315.28M | -559.76M | -864.41M | -2.21B | -1.83B | |
| -312.76M | -547.03M | -892.87M | -2.10B | -1.83B | |
| -5.64 | -10.54 | -18.37 | -50.20 | -56.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 167.20M | 561.57M | 944.07M | 1.32B | 1.55B | |
| 1.12B | 1.38B | 1.67B | 2.54B | 2.07B | |
| 611.11M | 661.39M | 568.19M | 803.04M | 503.61M | |
| 417.08M | 438.77M | 221.84M | 413.26M | 22.28M | |
| 508.59M | 716.06M | 1.10B | 1.74B | 1.51B |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -171.06M | -319.58M | -295.50M | -252.20M | -253.82M | |
| -240.29M | -62.24M | -80.69M | -67.39M | -73.26M | |
| 17.77M | -1.74M | -3.22M | 95.34M | 1.53B | |
| -7.09M | -61.89M | -36.37M | -52.27M | -56.52M | |
| -393.37M | -383.84M | -380.00M | -223.35M | 1.21B |
